Public hearings and witnesses
Monday, 18 May 2017—Sydney
ARMSTRONG, Mr James, Member, Consumer Advisory Panel,
GI-Cancer Institute, Australasian Gastro-Intestinal Trials Group
BARREAU, Ms Jackie, Member, Cancer Voices South Australia
BUCKLAND, Associate Professor Michael, Private capacity
BUTOW, Professor Phyllis, President, Clinical Oncology
Society of Australia
CANFELL, Professor Karen, Director of Research, Cancer Council
NSW, Cancer Council Australia
CHRISTENSEN, Ms Christine, Chair, Cancer Voices South
Australia, and Executive Member, Cancer Voices Australia
CONLEY, Mr Russell, Chief Executive Officer, Australasian
Gastro-Intestinal Trials Group
CULLEN, Mr Alexander, Ambassador, Cure Brain Cancer
Foundation
ESLICK, Professor Guy, Professor of Cancer Epidemiology and
Medical Statistics, University of Sydney
FERGUSON, Ms Linda, Private capacity
GRAEBER, Professor Manuel, Barnet-Cropper Chair of Brain
Tumour Research, Brain and Mind Centre, University of Sydney
HARPER, Mr Todd, Chief Executive Officer, Cancer Council
Victoria, Cancer Council Australia
JOHNS, Professor Terrance, Director, Brain Cancer Discovery
Collaborative
KENT, Mr Dan, Past Chair, Consumer Advisory Panel,
Australasian Gastro-Intestinal Trials Group
KOH, Dr Eng-Siew, Deputy Chair, Management Committee, and
Deputy Chair, Scientific Advisory Committee, Cooperative Trials Group for
Neuro-Oncology, NHMRC Clinical Trials Centre, University of Sydney
MARKER, Ms Julie, Executive Teams, Cancer Voices Australia
and Cancer Voices South Australia
MARKER, Ms Julie, Member, Consumer Advisory Panel,
Australasian Gastro-Intestinal Trials Group
MUMFORD, Ms Jan, Member, Consumer Advisory Panel, GI-Cancer
Institute, Australasian Gastro-Intestinal Trials Group
O'NEILL, Associate Professor Geraldine, Chief Investigator,
Brain Cancer Discovery Collaborative
ROSENTHAL, Professor Mark, Chair, Cooperative Trials Group
for Neuro-Oncology, NHMRC Clinical Trials Centre, University of Sydney
SHONK, Mr Evan, Private capacity
SHONK, Mrs Margaret, Private capacity
SIMES, Professor R John, Executive Member, Cooperative
Trials Group for Neuro-Oncology; and Director, NHMRC Clinical Trials Centre,
University of Sydney
TURPIE, Mrs Suzanne, Private capacity
VINES, Mr Richard, Chief Executive Officer, Rare Cancers
Australia
WOODS, Mrs Sandra Joy, Private capacity
Friday, 19 May 2017—Sydney
BYRNE, Professor Jennifer Anne, Head, Children's Cancer
Research Unit, the Children's Hospital at Westmead
KELSO, Professor Anne, Chief Executive Officer, National
Health and Medical Research Council
KERR, Mrs Jane, General Manager, Thoracic Cancer and Rare
Lung Disease, Lung Foundation Australia
LEIGH, Ms Lillian, Consumer/Lung Cancer Patient Advocate,
Lung Foundation Australia
ORCHARD, Mr Peter, Chief Executive Officer, CanTeen
Australia
PARKINSON, Dr Jonathon, Chair, New South Wales Oncology
Group, Neuro-oncology
PAVLAKIS, Associate Professor Nick, President, Australasian
Lung Cancer Trials Group, Lung Foundation Australia
PETERS, Professor Matthew, Professor Respiratory Medicine,
Thoracic Society of Australia and New Zealand
STEIN, Dr Brian, Medical Oncology Group of Australia
Tuesday, 6 June 2017—Brisbane
ARMSTRONG, Ms Zoe, Clinical
Research Director, Merck Sharpe & Dohme Australia
BUNT, Dr Jens, Research Fellow and
Team Leader, NFI Research Lines, Brain Development and Disorders Laboratory,
Queensland Brain Institute, The University of Queensland
BURGETT, Mrs Raechel, Private
capacity
DAY, Dr Bryan William, Team Head,
Translational Brain Cancer Research Laboratory, QIMR Berghofer Medical Research
Institute
LIM, Mrs Evangeline, Private
capacity
LITTLEFIELD, Mr Barrie, Head of
Engagement, Cure Brain Cancer Foundation
NELSON, Ms Marilyn, Private
capacity
RAYMOND, Ms Emma, Theme Leader,
Cancer, Wesley Medical Research
RICHARDS, Professor Linda, Deputy
Director, Research, Queensland Brain Institute, The University of Queensland
SELLARS, Mr Christian, Director,
Market Access and Public Affairs, Merck Sharpe & Dohme Australia
SPITERI, Mr Carmel, Team Leader,
Market Access, Merck Sharpe & Dohme Australia
STEWART, Ms Michelle, Head of
Research Strategy, Cure Brain Cancer Foundation
TAYLOR, Mrs Tracy, Private capacity
WADDELL, Dr Nicola, Group Leader,
Medical Genomics Group, QIMR Berghofer Medical Research Institute
WALKER, Professor David, Private
capacity
WHITEMAN, Professor David, Deputy
Director, QIMR Berghofer Medical Research Institute
Wednesday, 7 June 2017—Melbourne
AKHURST, Mr Tom, Private capacity
DE ROSE, Dr Robert, Co-founder, The Isabella and Marcus
Paediatric Brainstem Tumour Fund
FRASER, Dr Chris, Chair, Australian and New Zealand
Children's Haematology/Oncology Group
GOTTARDO, Clinical Associate Professor Nicholas, Deputy
Chair, Australian and New Zealand Children's Haematology/Oncology Group; and
Chair, Central Nervous System Tumour Subcommittee, Australian and New Zealand
Children's Haematology/Oncology Group
GOULBURN, Mr Daniel, Member, Pancreatic Cancer Alliance
GRAY, Mr Simon, Private capacity
GRAY, Mrs Carly, Private capacity
HERTZBERG, Professor Mark, Member and Director, Australasian
Leukaemia and Lymphoma Group
JOHNSON, Dr Elizabeth, Program Manager, Victorian
Comprehensive Cancer Centre
KEMPEN, Mr Peter, Chairman of the Board, Australasian
Leukaemia and Lymphoma Group
LEYDEN, Ms Simone, Chief Executive Officer and Co-founder,
Unicorn Foundation
MILLIS, Mrs Nicole, Executive Officer, Rare Voices Australia
MULLINS, Mr Greg, Head of Policy, Research Australia
PAJIC, Dr Marina, Group Leader, Garvan Institute of Medical
Research
PEACOCK, Mrs Catherine, Private capacity
PERRY, Mr Dustin, Private capacity
ROBERTS, Professor Andrew, Member and Director, Australasian
Leukaemia and Lymphoma Group
ROSENTHAL, Professor Mark, Clinical Trials Lead, Victorian
Comprehensive Cancer Centre
SMITH, Ms Delaine, Chief Executive Officer, Australasian
Leukaemia and Lymphoma Group
STRONG, Ms Robyn, Executive Officer, Australian and New
Zealand Children's Haematology/Oncology Group
WESTHORPE, Mr Barry David, Chief Executive Officer, Pancare
Foundation Inc.
WRIGHT, Associate Professor Gavin, Research and Education
Lead, Lung Cancer, Victorian Comprehensive Cancer Centre
Thursday, 8 June 2017—Canberra
AUNEDI, Mrs Helen, Country Head,
Country Clinical Operations, Roche Australia Pty Ltd
BERMAN, Mrs Tricia, Secretary,
Brain Tumour Alliance Australia
DE SOMER, Ms Elizabeth, Director of
Policy and Research, Medicines Australia
FRAZER, Professor Ian, Chair,
Australian Medical Research Advisory Board
GRADY, Dr Melissa, Regional
Director, Site Management and Monitoring, Asia Middle East and Africa Clinical
Operations, AstraZeneca
HAMPTON, Ms Blanche, Head, Strategy
and Partnership, Garvan Institute of Medical Research
HARVEY, Mr Justin, Unit Head,
Cancer and Screening, Health Group, Australian Institute of Health and Welfare
HINDSON, Mrs Catherine, Chair,
Brain Tumour Alliance Australia
MOON, Dr Lynelle, Group Head,
Health Group, Australian Institute of Health and Welfare
PARSONS, Mrs Alice, Committee
Member, Brain Tumour Alliance Australia
PITT, Ms Susan, Private capacity
SHEEHAN, Ms Nicola, Committee
Member, Brain Tumour Alliance Australia
STEEL, Mr Philip, Vice-Chair, Brain
Tumour Alliance Australia
STRANGMAN, Mr Denis, AM, Private
capacity
THOMAS, Professor David, Director,
The Kinghorn Cancer Centre; Head, Cancer Research Division, Garvan Institute of
Medical Research
WILLIAMS, Mr William (Billy),
Private capacity
Friday, 4 August 2017—Melbourne
BLAKEMORE, Mrs Carolyn, Consumer, Australian and New Zealand
Children's Haematology/Oncology Group National Patient and Carer Advisory Group
BRIGGS, Miss Sophie, Private capacity
BRIGGS, Mrs Teresa, Private capacity
DENEHEY, Dr Sigrid, Private capacity
EMBERSON, Ms Jill, Patient and Consumer Advocate, Ovarian
Cancer Australia
FOX, Professor Stephen, Director of Pathology, Peter
MacCallum Cancer Centre
HARPER, Mr Todd Andrew, Chief Executive Officer, Cancer
Council Victoria
HIBBERT, Mr Laurence, Member, Australian and New Zealand
Children's Haematology/Oncology Group National Patient and Carer Advisory Group
HILL, Ms Jane, Chief Executive Officer, Ovarian Cancer
Australia
IOCCO-FISCHER, Ms Melissa, Private capacity
KAY, Ms Anne, Chair, Australian and New Zealand Children's
Haematology/Oncology Group National Patient and Carer Advisory Group
KENNEDY, Ms Laura, Private capacity
LAMBERT, Dr Ken, Private capacity
ROBERTS, Professor Andrew, Head of Clinical Translation,
Walter and Eliza Hall Institute of Medical Research
SCOTT, Professor Clare Scott, Head, Rare Cancer Research,
Walter and Eliza Hall Institute of Medical Research
SEYMOUR, Professor John, Director, Department of
Haematology, and Associate Director, Clinical Research, Peter MacCallum Cancer
Centre
SLOCOMBE, Dr Judith, Chair, Consumer Advisory Panel, Walter
and Eliza Hall Institute of Medical Research
WITHINGTON, Mr Brett, Private capacity
Tuesday, 29 August 2017—Canberra
BUTT, Dr Alison, Senior Scientific
Officer, Cancer Australia
CREELMAN, Ms Alice, Assistant
Secretary, Department of Health
DE ABREU LOURENCO, Dr Richard,
Member, Australian Health Economics Society
GILES, Adjunct Associate Professor
Christine, Executive Director, Cancer Australia
GLOVER, Dr Julie, Acting Executive
Director, Research Programs, National Health and Medical Research Council
HARTLAND, Mr Nicholas, First
Assistant Secretary, Research, Data and Evaluation, Department of Health
JACKSON, Dr Paul, Acting General
Manager, Knowledge Management, Cancer Australia
JENKINSON, Dr David, Chief
Scientific Officer, The Brain Tumour Charity
KELSO, Professor Anne, Chief
Executive Officer, National Health and Medical Research Council
KNEIPP, Ms Erica, Assistant
Secretary, Department of Health
REYNOLDS, Ms Leanne, Head of
Research, Pancreatic Cancer UK
SHAKESPEARE, Ms Penny, First
Assistant Secretary, Department of Health
VINEY, Professor Rosalie, Member,
Australian Health Economics Society
WILSON, Professor Andrew, Chair,
Pharmaceutical Benefits Advisory Committee
Navigation: Previous Page | Contents